Zero Point Five Therapeutics, Inc. — Form D
Zero Point Five Therapeutics, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2025-04-17. The offering totals $5.3M, of which $4.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-04-17
- Form: D
- Accession: 0002054934-25-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.3M
- Amount sold: $4.3M
- Remaining: $1.0M
- Investors: 10
- Date of first sale: 2025-04-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-543974
Issuer
- Name: Zero Point Five Therapeutics, Inc.
- CIK: 0001985295
- Entity type: Corporation
- Jurisdiction: DISTRICT OF COLUMBIA
- Incorporated: 2018
- Address: 915 S. EATON STREET, BALTIMORE, MD, 21224
- Phone: 301-327-0118
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Joseph Amprey III | Director | Baltimore, MD |
| Ben Auspitz | Director | Cambridge, MA |
| Jodi Jahic | Director | Baltimore, MD |
| Joseph Amprey III | Executive Officer | Baltimore, MD |
Other filings by this issuer (1)
More